Finally, to confirm that 1833 would not be neutralized by autoantibodies in patients with SLE, we determined whether patients with SLE have Abs against 1833 as well as their relationship with anti-DNASE1 and anti-DNASE1L3 autoantibodies. The gene discussed is DNASE1; the disease is systemic lupus erythematosus.